LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
BD announced the launch of BD Neopak 2.25mL prefillable glass syringes intended for biopharmaceutical manufacturers that handle high-value and sensitive biologic agents that require higher quality ...
Becton, Dickinson and Company BDX, popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe, expanding its Neopak Glass Prefillable Syringe ...
Becton, Dickinson and Company (BD) and Ypsomed have announced an expansion of their partnership with the development of a 5.5ml version of the BD Neopak XtraFlow glass prefillable syringe. The new ...
BD Effivax TM Glass Prefillable Syringe Features Enhanced Technology that Builds on Company's Decades of Expertise in the Prefillable Syringe Market and Supports Customers' Manufacturing Needs ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe and the latest capacity expansion ...
The new BD Effivax™ Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing. “As ...
BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced the commercial release of the BD NeopakTM XtraFlowTM Glass Prefillable Syringe and the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results